Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeff Cuff"'
Autor:
Sarsha Yap, Emily He, Sam Egger, David E Goldsbury, Jie-Bin Lew, Preston J Ngo, Joachim Worthington, Hannah Rillstone, John R Zalcberg, Jeff Cuff, Robyn L Ward, Karen Canfell, Eleonora Feletto, Julia Steinberg
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Colorectal cancer is the third most diagnosed cancer globally and the second leading cause of cancer death. We examined colon and rectal cancer treatment patterns in Australia. Methods From cancer registry records, we identified 1
Externí odkaz:
https://doaj.org/article/e71f2531479c4192a19268b876edc3ce
Autor:
Ho Wai Derrick Siu, Niall Tebbutt, Lorraine Chantrill, Chris Karapetis, Christopher Steer, Kate Wilson, David Espinoza, Lisa Bailey, Sonia Yip, Jeff Cuff, Nick Pavlakis, Subotheni Thavaneswaran, Karen Briscoe, Ratnesh Srivastav, Jennifer Shannon, Eva Segelov, Jeannie Tie, Susan Caird, Alessandra Francesconi, Timothy Price, Melanie Wuttke, Rahul Ladwa, Katrin Sjoquist, Matthew Burge
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Doublet chemotherapy in combination with a biologic agent has been a standard of care in patients with metastatic colorectal cancer for over a decade. The evidence for a “lighter” treatment approach is limited to mono-chemothe
Externí odkaz:
https://doaj.org/article/fde8f6085457444da73ce4c379983bf2
Autor:
Emily Banks, Ian M Frayling, Kate Broun, Eleonora Feletto, James G Kench, Daniel L Worthley, Robyn L Ward, Michael Caruana, Karen Canfell, Carol Holden, Susan Morris, Katherine Tucker, Bonny Parkinson, Jie-Bin Lew, Joachim Worthington, Emily He, Katherine Butler, Harriet Hui, Karen Barclay, Alison Butt, Rob Carter, Jeff Cuff, Anita Dessaix, Hooi Ee, Paul Grogan, Christopher Horn, Maarit A Laaksonen, Barbara Leggett, Gillian Mitchell, D James St John, Linda Taoube
Publikováno v:
BMJ Open, Vol 10, Iss 6 (2020)
Introduction With almost 50% of cases preventable and the Australian National Bowel Cancer Screening Program in place, colorectal cancer (CRC) is a prime candidate for investment to reduce the cancer burden. The challenge is determining effective way
Externí odkaz:
https://doaj.org/article/1dfc8f3f44dc4140b2e4516531e001e0
Autor:
Frances L. Byrne, Ellen M. Olzomer, Gabriella R. Marriott, Lake-Ee Quek, Alice Katen, Jacky Su, Marin E. Nelson, Gene Hart-Smith, Mark Larance, Veronica F. Sebesfi, Jeff Cuff, Gabriella E. Martyn, Elizabeth Childress, Stephanie J. Alexopoulos, Ivan K. Poon, Maree C. Faux, Antony W. Burgess, Glen Reid, Joshua A. McCarroll, Webster L. Santos, Kate GR. Quinlan, Nigel Turner, Daniel J. Fazakerley, Naresh Kumar, Kyle L. Hoehn
Publikováno v:
Redox Biology, Vol 28, Iss , Pp - (2020)
A hallmark of cancer cells is their ability to reprogram nutrient metabolism. Thus, disruption to this phenotype is a potential avenue for anti-cancer therapy. Herein we used a phenotypic chemical library screening approach to identify molecules that
Externí odkaz:
https://doaj.org/article/5e4c5baf666144d5a43fe60f14c4e6fb
Autor:
Alison J. Butt, Gillian Mitchell, Melanie Wakefield, Linda Taoube, Natalie Taylor, Kate Broun, Emily Banks, Joachim Worthington, D. James B. St. John, Bruce K. Armstrong, Barbara A. Leggett, Mark A. Jenkins, Karen Canfell, Finlay A. Macrae, Eleonora Feletto, Bonny Parkinson, Harriet Hui, Hooi C. Ee, Susan H. Morris, Jie-Bin Lew, Robyn L. Ward, Anita Dessaix, Maarit A. Laaksonen, Carol A Holden, Rob Carter, Katherine L. Tucker, Karen L. Barclay, Emily He, Aung Ko Win, Daniel L. Worthley, Michael Caruana, Ian M. Frayling, Jeff Cuff, Jon Emery, Christopher Horn, James G. Kench, Katherine Butler, Paul Grogan
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 6 (2020)
BMJ Open, Vol 10, Iss 6 (2020)
IntroductionWith almost 50% of cases preventable and the Australian National Bowel Cancer Screening Program in place, colorectal cancer (CRC) is a prime candidate for investment to reduce the cancer burden. The challenge is determining effective ways
Autor:
Niall C. Tebbutt, Lorraine A. Chantrill, Louise M. Nott, David Espinoza, Sonia Yip, Christopher Steer, Matthew Burge, Christos S. Karapetis, Martinus Oostendorp, Katrin Marie Sjoquist, Jeff Cuff
Publikováno v:
Journal of Clinical Oncology. 38:TPS271-TPS271
TPS271 Background: Pan added to combination chemotherapy is established first-line therapy for RAS and BRAF wild type mCRC. Elderly patients are not well represented in clinical trials and may be more suited to treatment protocols with lower toxicity